Tetramer Formation of Tumor Suppressor Protein p53: Structure, Function, and Applications

被引:88
|
作者
Kamada, Rui [1 ]
Toguchi, Yu [1 ]
Nomura, Takao [2 ]
Imagawa, Toshiaki [1 ]
Sakaguchi, Kazuyasu [1 ]
机构
[1] Hokkaido Univ, Biol Chem Lab, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan
[2] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
关键词
cancer; tumor suppressor; oligomerization; structure; bio-nanomaterials; LI-FRAUMENI-SYNDROME; DNA-BINDING DOMAIN; CANCER-ASSOCIATED MUTANT; TP53 MUTATION DATABASE; S-ALKYL THIOESTER; C-TERMINAL DOMAIN; WILD-TYPE P53; OLIGOMERIZATION DOMAIN; CRYSTAL-STRUCTURE; NUCLEAR EXPORT;
D O I
10.1002/bip.22772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetramer formation of p53 is essential for its tumor suppressor function. p53 not only acts as a tumor suppressor protein by inducing cell cycle arrest and apoptosis in response to genotoxic stress, but it also regulates other cellular processes, including autophagy, stem cell self-renewal, and reprogramming of differentiated cells into stem cells, immune system, and metastasis. More than 50% of human tumors have TP53 gene mutations, and most of them are missense mutations that presumably reduce tumor suppressor activity of p53. This review focuses on the role of the tetramerization (oligomerization), which is modulated by the protein concentration of p53, posttranslational modifications, and/or interactions with its binding proteins, in regulating the tumor suppressor function of p53. Functional control of p53 by stabilizing or inhibiting oligomer formation and its bio-applications are also discussed. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:598 / 612
页数:15
相关论文
共 50 条
  • [41] Emerging Roles of the Tumor Suppressor p53 in Metabolism
    Yu, Lili
    Wu, Meng
    Zhu, Gaoyang
    Xu, Yang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [42] The regulation of cellular metabolism by tumor suppressor p53
    Yingjian Liang
    Juan Liu
    Zhaohui Feng
    Cell & Bioscience, 3
  • [43] The positive regulation of p53 by the tumor suppressor VHL
    Roe, Jae-Seok
    Youn, Hong-Duk
    CELL CYCLE, 2006, 5 (18) : 2054 - 2056
  • [44] Interaction of Tumor Suppressor p53 with DNA and Proteins
    Wang, Jianxiu
    Yang, Julei
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (01) : 122 - 127
  • [45] Deciphering the PTM codes of the tumor suppressor p53
    Wen, Jia
    Wang, Donglai
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (11) : 774 - 785
  • [46] Tumor suppressor p53 stole the AKT in hypoxia
    Yun, Zhong
    Glazer, Peter M.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (06) : 2264 - 2266
  • [47] p53: a tumor suppressor hiding in plain sight
    Baker, Suzanne J.
    Vogelstein, Bert
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (07) : 536 - 538
  • [48] Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
    Borrero, Liz J. Hernandez
    El-Deiry, Wafik S.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [49] The tumor suppressor p53:: mechanism of action in proliferation and cell death
    Mendoza-Rodríguez, CA
    Cerbón, MA
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2001, 53 (03): : 266 - 273
  • [50] Structure-function-rescue: the diverse nature of common p53 cancer mutants
    Joerger, A. C.
    Fersht, A. R.
    ONCOGENE, 2007, 26 (15) : 2226 - 2242